Anika Therapeutics Stock Market Value
| ANIK Stock | USD 17.20 0.23 1.36% |
| Symbol | Anika |
Anika Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.51) | Earnings Share (6.73) | Revenue Per Share 11.139 | Quarterly Revenue Growth (0.07) | Return On Assets (0.04) |
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Anika Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Anika Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Anika Therapeutics.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in Anika Therapeutics on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding Anika Therapeutics or generate 0.0% return on investment in Anika Therapeutics over 510 days. Anika Therapeutics is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthoped... More
Anika Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Anika Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Anika Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 34.28 | |||
| Value At Risk | (2.96) | |||
| Potential Upside | 3.23 |
Anika Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Anika Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Anika Therapeutics' standard deviation. In reality, there are many statistical measures that can use Anika Therapeutics historical prices to predict the future Anika Therapeutics' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.15) | |||
| Treynor Ratio | (0.33) |
Anika Therapeutics Backtested Returns
Anika Therapeutics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13% return per unit of risk over the last 3 months. Anika Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Anika Therapeutics' Risk Adjusted Performance of (0.08), standard deviation of 4.14, and Mean Deviation of 1.75 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.52, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Anika Therapeutics will likely underperform. At this point, Anika Therapeutics has a negative expected return of -0.53%. Please make sure to confirm Anika Therapeutics' skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Anika Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.56 |
Good reverse predictability
Anika Therapeutics has good reverse predictability. Overlapping area represents the amount of predictability between Anika Therapeutics time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Anika Therapeutics price movement. The serial correlation of -0.56 indicates that roughly 56.0% of current Anika Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.56 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 8.08 |
Anika Therapeutics lagged returns against current returns
Autocorrelation, which is Anika Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Anika Therapeutics' stock expected returns. We can calculate the autocorrelation of Anika Therapeutics returns to help us make a trade decision. For example, suppose you find that Anika Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Anika Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Anika Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Anika Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Anika Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Anika Therapeutics Lagged Returns
When evaluating Anika Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Anika Therapeutics stock have on its future price. Anika Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Anika Therapeutics autocorrelation shows the relationship between Anika Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Anika Therapeutics.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Anika Therapeutics Correlation, Anika Therapeutics Volatility and Anika Therapeutics Alpha and Beta module to complement your research on Anika Therapeutics. For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Anika Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.